Administration of Oral Extended Release Minocycline for Assessment of Skin and Plasma Concentrations of Minocycline

Completed · Phase 4

Conditions studied: Acne

In brief

The primary objective of this study is to evaluate the skin and plasma concentrations of minocycline in subjects undergoing treatment of acne vulgaris with oral extended release minocycline. Acne lesion counts and safety/tolerance of the treatment will also be evaluated.

Key facts

Study ID: NCT02695446
Run by: BioPharmX, Inc.
People needed: 12
Starts: 2016-03-01
Expected to finish: 2016-05-01
Last updated by the study team: 2017-09-14

Who can join

Age: 14 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

Otherwise healthy male and female subjects 14 to 40 years of age
Moderate to severe inflammatory facial acne vulgaris (EGSA score of 3-5)
Subjects not using oral or topical antibiotic products for at least 30 days prior to study entry and willing to refrain from use of oral and topical antibiotics for the duration of study participation
Subjects not currently using and willing to refrain from use of other topical acne products for the duration of study participation

You may not qualify if…

Mild, non-inflammatory or nodular acne vulgaris
Have current or previous skin cancer
Have a history of skin disease or presence of skin condition the PI believes would interfere with the study
Females who report that they are pregnant, planning a pregnancy during the study period or breastfeeding
Have conditions or factors that the PI believes may affect the response of the skin or the interpretation of the results
Participation in any clinical study within the previous 30 days or plan concurrent participation in other studies

Where it is running

KGL Skin Study Center — Broomall, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.